Literature DB >> 9933620

Crystal structure of neuropsin, a hippocampal protease involved in kindling epileptogenesis.

T Kishi1, M Kato, T Shimizu, K Kato, K Matsumoto, S Yoshida, S Shiosaka, T Hakoshima.   

Abstract

Neuropsin is a novel serine protease, the expression of which is highly localized in the limbic areas of the mouse brain and which is suggested to be involved in kindling epileptogenesis and hippocampal plasticity. The 2.1-A resolution crystal structure of neuropsin provides the first three-dimensional view of one of the serine proteases highly expressed in the nervous system, and reveals a serine protease fold that exhibits chimeric features between trypsin and nerve growth factor-gamma (NGFgamma), a member of the kallikrein family. Neuropsin possesses an N-glycosylated "kallikrein loop" but forms six disulfide bonds corresponding to those of trypsin. The ordered kallikrein loop projects proline toward the active site to restrict smaller residues or proline at the P2 position of substrates. Loop F, which participates in forming the S3/S4 sites, is similar to trypsin rather than NGFgamma. The unique conformations of loops G and H form an S1 pocket specific for both arginine and lysine. These characteristic loop structures forming the substrate-binding site suggest the novel substrate specificity of neuropsin and give a clue to the design of its specific inhibitors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933620     DOI: 10.1074/jbc.274.7.4220

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Conformational selection in trypsin-like proteases.

Authors:  Nicola Pozzi; Austin D Vogt; David W Gohara; Enrico Di Cera
Journal:  Curr Opin Struct Biol       Date:  2012-06-03       Impact factor: 6.809

2.  Spontaneous proton transfer to a conserved intein residue determines on-pathway protein splicing.

Authors:  Brian Pereira; Philip T Shemella; Gil Amitai; Georges Belfort; Saroj K Nayak; Marlene Belfort
Journal:  J Mol Biol       Date:  2010-12-23       Impact factor: 5.469

Review 3.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

Review 4.  Allostery in trypsin-like proteases suggests new therapeutic strategies.

Authors:  David W Gohara; Enrico Di Cera
Journal:  Trends Biotechnol       Date:  2011-07-02       Impact factor: 19.536

5.  N-glycan structures of murine hippocampus serine protease, neuropsin, produced in Trichoplusia ni cells.

Authors:  N Takahashi; Y Tsukamoto; S Shiosaka; T Kishi; T Hakoshima; Y Arata; Y Yamaguchi; K Kato; I Shimada
Journal:  Glycoconj J       Date:  1999-08       Impact factor: 2.916

6.  Crystallographic and kinetic evidence of allostery in a trypsin-like protease.

Authors:  Weiling Niu; Zhiwei Chen; Prafull S Gandhi; Austin D Vogt; Nicola Pozzi; Leslie A Pelc; Fatima Zapata; Enrico Di Cera
Journal:  Biochemistry       Date:  2011-06-30       Impact factor: 3.162

7.  The autolytic regulation of human kallikrein-related peptidase 6.

Authors:  Sachiko I Blaber; Hyesook Yoon; Isobel A Scarisbrick; Maria Aparecida Juliano; Michael Blaber
Journal:  Biochemistry       Date:  2007-04-07       Impact factor: 3.162

Review 8.  Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).

Authors:  Peter Goettig; Viktor Magdolen; Hans Brandstetter
Journal:  Biochimie       Date:  2010-07-06       Impact factor: 4.079

9.  Structure-function analyses of human kallikrein-related peptidase 2 establish the 99-loop as master regulator of activity.

Authors:  Wolfgang Skala; Daniel T Utzschneider; Viktor Magdolen; Mekdes Debela; Shihui Guo; Charles S Craik; Hans Brandstetter; Peter Goettig
Journal:  J Biol Chem       Date:  2014-10-16       Impact factor: 5.157

Review 10.  The role of proteases in regulating Eph/ephrin signaling.

Authors:  Lakmali Atapattu; Martin Lackmann; Peter W Janes
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.